Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation
Neutropenia is an important complication of high-dose chemotherapy (HDCT). Neutropenic patients presenting with fever are routinely hospitalized for treatment with broad-spectrum antibiotics. Neutropenia up to 10 days is associated with a low-risk profile, and antimicrobial therapy administered on a...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
July 2000
|
| In: |
International journal of antimicrobial agents
Year: 2000, Jahrgang: 15, Heft: 2, Pages: 119-123 |
| ISSN: | 1872-7913 |
| DOI: | 10.1016/S0924-8579(00)00155-2 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S0924-8579(00)00155-2 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0924857900001552 
|
| Verfasserangaben: | Gerlinde Egerer, Hartmut Goldschmidt, Hans Salwender, Ute Hegenbart, Ingrid Ehrhard, Rainer Haas, Anthony D Ho |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1782686916 | ||
| 003 | DE-627 | ||
| 005 | 20220820100635.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211221s2000 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0924-8579(00)00155-2 |2 doi | |
| 035 | |a (DE-627)1782686916 | ||
| 035 | |a (DE-599)KXP1782686916 | ||
| 035 | |a (OCoLC)1341436565 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Egerer, Gerlinde |e VerfasserIn |0 (DE-588)105502168X |0 (DE-627)792516745 |0 (DE-576)167430882 |4 aut | |
| 245 | 1 | 0 | |a Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation |c Gerlinde Egerer, Hartmut Goldschmidt, Hans Salwender, Ute Hegenbart, Ingrid Ehrhard, Rainer Haas, Anthony D Ho |
| 264 | 1 | |c July 2000 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 21.12.2021 | ||
| 520 | |a Neutropenia is an important complication of high-dose chemotherapy (HDCT). Neutropenic patients presenting with fever are routinely hospitalized for treatment with broad-spectrum antibiotics. Neutropenia up to 10 days is associated with a low-risk profile, and antimicrobial therapy administered on an outpatient basis might be an alternative to admission to hospital. This prospective study evaluates the safety of a continuous infusion of ceftazidime in neutropenic patients after HDCT and peripheral blood stem cell transplantation (PBSCT). From September 1995 to October 1999, 81 patients received a 2 g intravenous bolus of ceftazidime, followed by a 4 g continuous infusion per 24 h of ceftazidime using a portable infusion pump. If the fever persisted for 72 h, a glycopeptide antibiotic was added. The median patients’ age was 44 years. Fifty-two of 81 patients (64%) responded to the monotherapy with ceftazidime. After addition of a glycopeptide antibiotic, a further 17 patients (21%) became afebrile. The causes of fever were septicaemia in 11 patients, pneumonia in two and fever of unknown origin in 68 patients. Fifty-eight episodes (72%) were successfully managed by outpatient treatment alone. The reason for admission to hospital was the change to imipenem/cilastin, which had to be administered three times per day (12 patients), severe mucositis with parenteral nutrition (eight patients), or a Karnovsky index ≤60 (three patients). In six of these cases, outpatient treatment was resumed after a brief period of in-patient care. In no case was the treatment terminated because of failure of the pump. With daily follow-up and close monitoring for development of complications, it is possible to discharge patients earlier after HDCT and PBSCT, thereby decreasing costs. | ||
| 650 | 4 | |a Ceftazidime | |
| 650 | 4 | |a High-dose chemotherapy | |
| 650 | 4 | |a Neutropenia | |
| 650 | 4 | |a Outpatient treatment | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 700 | 1 | |a Salwender, Hans |e VerfasserIn |0 (DE-588)1114928666 |0 (DE-627)869399993 |0 (DE-576)477578233 |4 aut | |
| 700 | 1 | |a Hegenbart, Ute |e VerfasserIn |0 (DE-588)1028373708 |0 (DE-627)73062157X |0 (DE-576)35901903X |4 aut | |
| 700 | 1 | |a Ehrhard, Ingrid |e VerfasserIn |0 (DE-588)1077385323 |0 (DE-627)83645149X |0 (DE-576)16830998X |4 aut | |
| 700 | 1 | |a Haas, Rainer |d 1955- |e VerfasserIn |0 (DE-588)173773524 |0 (DE-627)698678141 |0 (DE-576)134613805 |4 aut | |
| 700 | 1 | |a Ho, Anthony Dick |d 1948- |e VerfasserIn |0 (DE-588)108692477 |0 (DE-627)504904205 |0 (DE-576)19010466X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of antimicrobial agents |d Amsterdam [u.a.] : Elsevier Science, 1991 |g 15(2000), 2, Seite 119-123 |h Online-Ressource |w (DE-627)32049781X |w (DE-600)2011829-6 |w (DE-576)264627466 |x 1872-7913 |7 nnas |a Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation |
| 773 | 1 | 8 | |g volume:15 |g year:2000 |g number:2 |g pages:119-123 |g extent:5 |a Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S0924-8579(00)00155-2 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0924857900001552 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20211221 | ||
| 993 | |a Article | ||
| 994 | |a 2000 | ||
| 998 | |g 108692477 |a Ho, Anthony Dick |m 108692477:Ho, Anthony Dick |d 910000 |d 910100 |e 910000PH108692477 |e 910100PH108692477 |k 0/910000/ |k 1/910000/910100/ |p 7 |y j | ||
| 998 | |g 1077385323 |a Ehrhard, Ingrid |m 1077385323:Ehrhard, Ingrid |d 910000 |d 911700 |e 910000PE1077385323 |e 911700PE1077385323 |k 0/910000/ |k 1/910000/911700/ |p 5 | ||
| 998 | |g 1114928666 |a Salwender, Hans |m 1114928666:Salwender, Hans |d 910000 |d 910100 |e 910000PS1114928666 |e 910100PS1114928666 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |e 910000PG102258023X |e 910100PG102258023X |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 105502168X |a Egerer, Gerlinde |m 105502168X:Egerer, Gerlinde |d 910000 |d 910100 |e 910000PE105502168X |e 910100PE105502168X |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1782686916 |e 402362263X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"title":[{"title_sort":"International journal of antimicrobial agents","title":"International journal of antimicrobial agents"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"extent":"5","issue":"2","year":"2000","pages":"119-123","volume":"15","text":"15(2000), 2, Seite 119-123"},"language":["eng"],"note":["Fortsetzung der Druck-Ausgabe","Gesehen am 13.11.15"],"pubHistory":["1.1991 -"],"name":{"displayForm":["International Society of Chemotherapy"]},"origin":[{"dateIssuedDisp":"1991-","publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1991","publisher":"Elsevier Science"}],"disp":"Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantationInternational journal of antimicrobial agents","type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"eki":["32049781X"],"zdb":["2011829-6"],"issn":["1872-7913"]},"recId":"32049781X"}],"physDesc":[{"extent":"5 S."}],"title":[{"title_sort":"Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation","title":"Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation"}],"note":["Gesehen am 21.12.2021"],"language":["eng"],"person":[{"display":"Egerer, Gerlinde","family":"Egerer","role":"aut","given":"Gerlinde"},{"display":"Goldschmidt, Hartmut","role":"aut","family":"Goldschmidt","given":"Hartmut"},{"given":"Hans","family":"Salwender","role":"aut","display":"Salwender, Hans"},{"family":"Hegenbart","role":"aut","display":"Hegenbart, Ute","given":"Ute"},{"given":"Ingrid","display":"Ehrhard, Ingrid","family":"Ehrhard","role":"aut"},{"given":"Rainer","family":"Haas","role":"aut","display":"Haas, Rainer"},{"given":"Anthony Dick","display":"Ho, Anthony Dick","family":"Ho","role":"aut"}],"recId":"1782686916","id":{"doi":["10.1016/S0924-8579(00)00155-2"],"eki":["1782686916"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"July 2000","dateIssuedKey":"2000"}],"name":{"displayForm":["Gerlinde Egerer, Hartmut Goldschmidt, Hans Salwender, Ute Hegenbart, Ingrid Ehrhard, Rainer Haas, Anthony D Ho"]}} | ||
| SRT | |a EGERERGERLEFFICACYOF2000 | ||